Assessing quality of life in patients with glaucoma using the glaucoma quality of life-15 (GQL-15) questionnaire

Journal of Glaucoma

Volumn 18, Issue 1, 2009, Pages 6-12

  Goldberg, Ivan ^a,e   Clement, Colin I ^a   Chiang, Tina H ^c   Walt, John G ^c   Lee, Lauren J ^d   Graham, Stuart ^a   Healey, Paul R ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c ALLERGAN INC   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e Eye Associates   (Australia)

Author keywords

Disease severity; Glaucoma; Glaucoma Quality of Life 15 Questionnaire; GQL 15; Quality of life

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BINOCULAR VISION; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DARK ADAPTATION; DISEASE SEVERITY; EVALUATION; EYE EXAMINATION; FEMALE; GLAUCOMA; HUMAN; LIGHT ADAPTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PERIPHERAL VISION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; VISION; VISUAL ACUITY; VISUAL FIELD; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; GLARE; HOSPITALIZATION; MIDDLE AGED; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PHYSIOLOGY; SICKNESS IMPACT PROFILE; VISUAL DISORDER;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DARK ADAPTATION; GLARE; GLAUCOMA, OPEN-ANGLE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; VISION DISORDERS; VISION, BINOCULAR; VISUAL ACUITY; VISUAL FIELDS;

EID: 63449128562     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3181752c83     Document Type: Article

References (19)

1. Nelson P, Aspinall P, Papasouliotis O, et al. Quality of life in glaucoma and its relationship with visual function. J Glaucoma. 2003;12:139-150.
2. Day DG, Sharpe ED, Atkinson MJ, et al. The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye. 2006;20: 583-590.
3. Hyman LG, Kamaroff E, Heijl A, et al. Treatment and vision-related quality of life in the Early Manifest Glaucoma Trial. Ophthalmology. 2005;112:1505-1513.
4. Nesher R, Ticho U. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide; effect on the quality of life of glaucoma patients with drug-related side effects. Isr Med Assoc J. 2003;5:260-263.
5. Javitt JD, Schiffman RM, Brimonidine Outcomes Study Group I. Clinical success and quality of life with brimonidine 0.2% or timolol 0.5% used twice daily in glaucoma or ocular hypertension: a randomized clinical trial. J Glaucoma. 2000;9: 224-234.
6. Stein JD. Disparities between ophthalmologists and their patients in estimating quality of life. Curr Opin Ophthalmology. 2004;15:238-243.
7. Nelson P, Aspinall P, O'Brien C. Patients' perception of visual impairment in glaucoma: a pilot study. Br J Ophthalmol. 1999; 83:546-552.
8. Iester M, Zingirian M. Quality of life in patients with early, moderate and advanced glaucoma. Eye. 2002;16:44-49.
9. Janz NK, Wren PA, Lichter PR, et al. The CIGTS Group. Quality of life in newly diagnosed glaucoma patients. Ophthalmology. 2001;108:887-898.
10. Jampel HD, Schwartz A, Pollack I, et al. Glaucoma patients' assessment of their visual function and quality of life. J Glaucoma. 2002;11:154-163.
11. Nah YS, Seong GJ, Kim CY. Visual function and quality of life in Korean patients with glaucoma. Korean J Ophthalmol. 2002;16:70-74.
12. Mangione CM, Lee PP, Gutierrez PR, et al. The National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Visual Function Questionnaire. Arch Ophthalmol. 2001;119: 1050-1058.
13. Mills RP, Janz NK, Wren PA, et al. Correlation of visual field with quality-of-life measures of diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS). J Glaucoma. 2001; 10:192-198.
14. Mangione CM, Phillips RS, Seddon JM, et al. Development of the 'Activities of Daily Vision Scale'. A measure of functional status. Med Care. 1992;30:1111-1126.
15. Sherwood MB, Garcia-Siekavizza A, Meltzer MI, et al. Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study. Ophthalmology. 1998;105:561-566.
16. Parrish RK. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma. Trans Am Ophthalmol Soc. 1996;94:919-1028.
17. Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115:777-784.
18. Mills RP, Budenz DL, Lee PP, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006;141:24-30.
19. Janz NK, Wren PA, Lichter PR, et al, CIGTS Study Group. The Collaboration Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108:1954-1965.